diclofenac sodium and misoprostol

FDA Drug Profile — Diclofenac Sodium Misoprostol, ARTHROTEC

Drug Details

Generic Name
diclofenac sodium and misoprostol
Brand Names
Diclofenac Sodium Misoprostol, ARTHROTEC
Application Number
ANDA205143
Sponsor
Bryant Ranch Prepack
NDC Codes
7
Dosage Forms
TABLET, DELAYED RELEASE, TABLET, FILM COATED
Routes
ORAL
Active Ingredients
DICLOFENAC SODIUM, MISOPROSTOL

Indications and Usage

1 INDICATIONS AND USAGE Diclofenac sodium and misoprostol delayed-release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in adult patients at high risk of developing NSAID-induced gastric and duodenal ulcers and their complications. For a list of factors that may increase the risk of NSAID-induced gastric and duodenal ulcers and their complications [see Warnings and Precautions (5.3) ]. Diclofenac sodium and misoprostol delayed-release tablets are a combination of diclofenac sodium, a non-steroidal anti-inflammatory drug, and misoprostol, a prostaglandin-1 (PGE1) analog, indicated for the treatment of signs and symptoms of osteoarthritis or rheumatoid arthritis in adult patients at high risk of developing NSAID-induced gastric and duodenal ulcers and their complications. ( 1 )